A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 27, 2024

Primary Completion Date

December 2, 2028

Study Completion Date

December 2, 2029

Conditions
B-cell MalignancyRelapsed CancerRefractory CancerB-cell Lymphoma
Interventions
DRUG

BGB-16673

Administered orally

DRUG

Sonrotoclax

Administered orally

DRUG

Zanubrutinib

Administered orally

DRUG

Mosunetuzumab

Administered subcutaneously

DRUG

Glofitamab

Administered intravenously

DRUG

Obinutuzumab

Administered intravenously

Trial Locations (50)

1023

RECRUITING

Auckland City Hospital, Auckland

10032

NOT_YET_RECRUITING

Columbia University Medical Center, New York

20089

NOT_YET_RECRUITING

Istituto Clinico Humanitas, Rozzano

20162

NOT_YET_RECRUITING

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milan

24105

NOT_YET_RECRUITING

Universitatsklinikum Schleswig Holstein, Campus Kiel, Kiel

37134

NOT_YET_RECRUITING

Centroricerche Cliniche Di Verona Srl, Verona

40138

NOT_YET_RECRUITING

Azienda Ospedaliera Universitaria Policlinico Santorsola Malpighi, Bologna

72076

NOT_YET_RECRUITING

Medizinische Universitaetsklinik, Tübingen

80131

NOT_YET_RECRUITING

Istituto Nazionale Tumori Fondazione G Pascale, Napoli

89081

NOT_YET_RECRUITING

Universitaetsklinikum Ulm, Ulm

90033

RECRUITING

University of Southern Californianorris Comprehensive, Los Angeles

215006

RECRUITING

The First Affiliated Hospital of Soochow University, Suzhou

310002

RECRUITING

The First Affiliated Hospital, Zhejiang University School of Medicinechengzhan, Hangzhou

325000

RECRUITING

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou

350001

RECRUITING

Fujian Medical University Union Hospital, Fuzhou

510060

RECRUITING

Sun Yat Sen University Cancer Center, Guangzhou

85054-4502

RECRUITING

Mayo Clinic Phoenix, Phoenix

32224-1865

RECRUITING

Mayo Clinic Jacksonville, Jacksonville

33612-9496

RECRUITING

Moffitt Cancer Center, Tampa

66205-2003

NOT_YET_RECRUITING

The University of Kansas Cancer Center, Westwood

55905-0001

RECRUITING

Mayo Clinic Rochester, Rochester

63110-1010

RECRUITING

Washington University School of Medicine, St Louis

07932-1049

RECRUITING

Summit Medical Group, Florham Park

10029-6504

RECRUITING

Icahn School of Medicine At Mount Sinai, New York

10065-4870

RECRUITING

Weill Cornell Medical College Newyork Presbyterian Hospital, New York

10065-6800

RECRUITING

Memorial Sloan Kettering Cancer Center Mskcc, New York

14642-0001

NOT_YET_RECRUITING

University of Rochester, Rochester

19111-2434

RECRUITING

Fox Chase Cancer Center, Philadelphia

77030-4009

RECRUITING

The University of Texas Md Anderson Cancer Center, Houston

84112-5550

RECRUITING

Huntsman Cancer Institute, Salt Lake City

53792-0001

RECRUITING

University of Wisconsin, Madison

53226-1222

NOT_YET_RECRUITING

Medical College of Wisconsin, Milwaukee

NSW 2217

RECRUITING

St George Hospital, Kogarah

QLD 4101

RECRUITING

Mater Cancer Care Centre, South Brisbane

VIC 3168

RECRUITING

Monash Health, Clayton

VIC 3000

RECRUITING

Peter Maccallum Cancer Centre, Melbourne

VIC 3004

RECRUITING

The Alfred Hospital, Melbourne

WA 6009

RECRUITING

Linear Clinical Research, Nedlands

70200-730

NOT_YET_RECRUITING

Hospital Sirio Libanes Brasilia, Brasília

41950-640

NOT_YET_RECRUITING

Ensino E Terapia de Inovacao Clinica Amo Etica, Salvador

15090-000

NOT_YET_RECRUITING

Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto, São José do Rio Preto

05653-120

NOT_YET_RECRUITING

Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein, São Paulo

01307

NOT_YET_RECRUITING

Universitatsklinikum Carl Gustav Carus An Der Technischen Universitat Dresden, Dresden

07747

NOT_YET_RECRUITING

Universitatsklinikum Jena Klinik Fur Innere Medizin Ii, Jena

0622

RECRUITING

North Shore Hospital, Auckland

80-214

NOT_YET_RECRUITING

Uniwersyteckie Centrum Kliniczne, Gdansk

20-081

NOT_YET_RECRUITING

Samodzielny Publiczny Szpital Kliniczny Nr W Lublinie, Lublin

10-228

NOT_YET_RECRUITING

Szpital Kliniczny Mswia Z Warmisko Mazurskim Centrum Onkologii, Olsztyn

45-061

NOT_YET_RECRUITING

Szpital Wojewodzki W Opolu Sp Z Oo Oddzia Hematologii I Onkologii Hematologicznej, Opole

02-781

NOT_YET_RECRUITING

Narodowy Instytut Onkologii Im Marii Sklodowskiej Curie Hematology Unit, Warsaw

Sponsors

Lead Sponsor

All Listed Sponsors
lead

BeiGene

INDUSTRY

NCT06634589 - A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies | Biotech Hunter | Biotech Hunter